Molecular Inflammation Board at the Center for Personalized Medicine

This study is evaluating a new kind of medical team — called a Molecular Inflammation Board — that brings together specialists to review complex inflammatory conditions and recommend personalized treatments. The goal is to see whether this approach improves care for patients with difficult-to-treat chronic inflammatory diseases. **You may be eligible if...** - You are 18 or older - You have a chronic inflammatory condition such as psoriasis, psoriatic arthritis, inflammatory bowel disease (Crohn's or colitis), or axial spondyloarthritis (a type of inflammatory back disease) - You are willing and able to give informed consent **You may NOT be eligible if...** - You lack the capacity to give informed consent Talk to your doctor to see if this trial is right for you.